Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Conference call interim report

Invitation to attend Vitrolife’s conference call regarding presentation of the interim report for the period January – September 2019. The presentation will be held in English.Time: Wednesday 6 November, 2019 at 10.00 a.m. CET. Registration can preferably be done 10 minutes before the conference start time on: Sweden dial in number: +46 (0)8 506 921 69  International dial in number: +44 (0) 203 0095709  Conference name: Vitrolife, conference ID: 6995418 Vitrolife participants:Thomas Axelsson, CEO Mikael Engblom, CFOThe press release for Vitrolife’s interim report will

Peikko to extend its cooperation with Riga Technical University in Latvia

Peikko Group Corporation has today signed a Memorandum of Understanding with Riga Technical University, RTU. The agreement was facilitated and co-signed with the Investment and Development Agency of Latvia, LIAA. The purpose is to significantly expand the cooperation between Peikko and RTU’s Faculty of Civil Engineering in the coming years. RTU is focused on becoming a third-generation university that provides high-quality education, but also conducts advanced research and ensures innovation and technology transfer, practically implementing scientific discoveries. Peikko and

Citycon to publish its Interim Report for January-September 2019 on Thursday, 24 October 2019 approximately at 9 am EEST

CITYCON OYJ   Investor News   17 October 2019 at 10:00 hrsCitycon will publish its Interim Report for 1 January – 30 September 2019 on Thursday, 24 October 2019 approximately at 9 am EEST. The report will be available on Citycon’s website immediately after publication.Citycon's investor, analyst and press conference call and live audiocasting will begin one hour later at 10 am EEST. The audiocast can be participated by calling in and followed live on the following website: https://citycon.videosync.fi/2019-q3-results  Conference call numbers are:Participants from Europe +44 3333 000

Oboya invests for a sustainable future - increased sales of environmentally friendly cultivation products

Oboya Horticulture Industries AB ("Oboya" or "the Company") has during the year invested in new machines and tools for easier conversion to production of environmentally friendly cultivation products that are degradable and recyclable and manufactured from Swedish biomaterials. The investments have resulted in continually orders from customers. Sales of environmentally friendly cultivation products are estimated at approximately SEK 11.9 million in 2019, while sales for the full year 2018 amounted to approximately SEK 1.0 million. Sales of environmentally friendly products are expected to

Trastuzumab deruxtecan granted FDA Priority Review

17 Oct 2019 07:00 BST Trastuzumab deruxtecan granted FDA Priority Review fortreatment of patients with HER2-positive metastatic breast cancer AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) today announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for [fam-] trastuzumab deruxtecan (DS-8201) and granted Priority Review.  The Prescription Drug User Fee Act (PDUFA) date for trastuzumab deruxtecan, a HER2-targeting antibody drug conjugate (ADC) and potential new medicine for the treatment of HER2-

ExpreS2ion’s joint venture AdaptVac receives Danish InnoBooster grant of 1.2 MSEK for for breast cancer studies in dogs

ExpreS2ion Biotech Holding AB (“ExpreS2ion”) announces today that its joint venture company AdaptVac ApS (“AdaptVac”) has been awarded an InnoBooster grant by the Danish Innovation Foundation worth 0.8 MDKK (approx. 1.2 MSEK). The grant provides further resources for the development of a safe and effective treatment for dogs diagnosed with DER2+ cancer. In addition to targeting the veterinary market for pets, the project will also generate supportive data for AV001, AdaptVac’s preclinical human HER2+ breast cancer program.The aim of the project is to develop veterinary cancer products,

JAYS announce their first “quiet” headphones

General press release Swedish lifestyle and audio product developer JAYS introduce their first product in the quiet (q-) series. The first product launched is an over-ear Active Noise Cancelling (ANC) headphone named q-Seven Wireless. q-Seven is developed with a focal point on high comfort and noise cancelling features with the goal to create a space of silence and focus for consumers in the city hustle. Next to the clean and simple design, which is characteristic for JAYS products, the target of q-Seven is to introduce the ANC to a new target group in a new environment. “ANC is

NPRO: Invitation to presentation of third quarter 2019

Norwegian Property ASA (OSE: NPRO, NPRO.OL) releases its third quarter results for 2019 on Thursday 24 October 2019, and we are pleased to invite investors, analysts and media to a presentation of the results. The presentation will be held in Norwegian only, and it will be held by Bent Oustad (CEO) and Haavard Rønning (CFO). Date: Thursday 24 October 2019Time: 08:30 a.m. Central European TimeLocation: Restaurant in 5th floor in Kaibygg I, entrance from Bryggegata 6 at Aker Brygge in Oslo, Norway The presentation will also be broadcasted live via webcast (in Norwegian only). The

Continued growth and strengthened margins

Summary of interim period, January–September 2019 · Net sales SEK 859 million (727) · EBITA SEK 194 million (156), with an EBITA margin of 22.6% (21.5) · Operating profit SEK 118.1 million (94.1), with an operating margin of 13.8% (12.9) · Profit after net financial items was SEK 108.8 million (86.3) · Earnings per share before dilution SEK 2.66 (2.25) · Cash flow from operating activities SEK 222 million (149) Summary of the period, July – September 2019 · Net sales SEK 289 million (262) · EBITA SEK 69.1 million (61.5), with an EBITA margin of 23.9% (23.5) ·

YIT and Meridiam chosen by the City of Espoo as the service provider for schools and daycare centres to be built according to a new model

YIT Corporation Press release October 17, 2019 at 9:30 a.m.YIT and Meridiam chosen by the City of Espoo as the service provider for schools and daycare centres to be built according to a new model The City of Espoo, Finland, has chosen a project company formed by YIT Corporation and Meridiam Investments II to take responsibility for the design, construction, financing and maintenance of a number of new schools and daycare centres to be built over the next five years. The City of Espoo arranged competitive bidding during the past year for a comprehensive service according to the Public-

Nomination committee appointed for PowerCell’s Annual General Meeting 2019

The annual general meeting decided on March 27, 2019, to appoint a nomination committee for PowerCell Sweden AB (publ), consisting of one representative each from the three largest shareholders as of September 30, 2019, plus one representative from the board of PowerCell. These representatives have now been appointed.The three largest shareholders in PowerCell as of 30 September 2019 were: Midroc New Technology AB, Fouriertransform AB and Finindus. The companies have appointed one representative each as below, and they, together with the representative from the board, form PowerCell’s

OptiFreeze signs an agreement with one of Europe's largest companies to dry vegetables and herbs

OptiFreeze has signed an agreement with one of Europe's largest companies operating in the drying of vegetables and herbs.The agreement means that OptiFreeze will conduct industrial trials together with the company and these are planned for December 2019. After the trials, both parties will jointly evaluate the results. Due to business and strategic reasons for the customer, OptiFreeze has chosen not to name the company for the time being. The company has been collaborating with OptiFreeze for some time and together we have carried out industrial scale tests on site in the customer's

Swedbank Robur ranked in top as responsible investor

Swedbank Robur ranks as number four when Hirschel & Kramers (H&K) lists how European Asset Managers work with responsible investments and sustainability. The ranking has evaluated Asset Managers based on several different sustainability perspectives, including how they communicate their work.This is the second consecutive year that Swedbank Robur is among the top five in Europe. “We are very pleased to be ranked in top. It is a clear acknowledgment that our continuously work with sustainability and responsible investments, and our employees' commitment to these issues, really makes a

Moody´s upgrades Fabege to Baa2, stable outlook

Fabege has received an upgraded credit rating of Baa2, with a stable outlook, from Moody’s.Fabege has been active on the capital market for many years via commercial paper and bonds, In June a new Green framework for financing was launched to which both the commercial paper programme of SEK 5bn and the MTN-programme of SEK 10bn are tied.  “For Fabege it is important to make investors aware of our high quality and our long-term approach. We’re delighted to have received this acknowledgement of the company’s financial stability via the upgrade from Moody’s,” commented Åsa Lind, Head of

Envirotainer Opens RAP e2 Station in Liège (LGG)

October 17th, 2019 - Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, today announced that they are upgrading their network of stations supporting their state-of-the-art e-technology container, the RAP e2, by adding Liège (LGG).“Europe is the #1 pharmaceutical region in the world, with exports exceeding €100 billion in 2017. Being the market leader in cold-chain solutions we subsequently have a very strong presence here since many years. The strongest reason for upgrading our Liège (LGG) station to also handle our RAP e2, even

Essity launches Virtual Reality app for Hand Hygiene education

Essity’s Tork brand launches Tork VR Clean Hands Training and Education, a solution specifically designed to make hand hygiene training more engaging and inspiring for healthcare professionals. This new and unique way of training is a result of our collaboration with world-leading hand hygiene experts at the Infection Prevention and Control Program at the University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland, and hospitals around the world.Hand hygiene is one of the most important tools in the fight against healthcare-associated infections. This new app is fulfilling

Interim Report January - September 2019

Strong development of cloud services and improvements in Business Unit WestJuly - September 2019 · Revenues decreased by 3% to SEK 701 (725) million. Change in local currencies was -4%. · Adjusted EBITA amounted to SEK 36.9 (45.3) million. · Profit before tax amounted to SEK 30.0 (37.4) million. · Profit after tax amounted to SEK 24.2 (27.8) million. · Profit per share amounted to 2.64 (3.02) SEK. · New contracts relating to cloud services worth SEK 87 (70) million has been concluded, an increase by 24%. January - September 2019 · Revenues increased by 3% to SEK

Diamyd Medical’s manufacturing process may be moved to a new manufacturer

Diamyd Medical AB announces that its manufacturing process of rhGAD65, the active ingredient in the diabetes vaccine Diamyd®, may be moved to a new manufacturer.Diamyd Medical’s CEO Ulf Hannelius and its founder Anders Essen-Moller report that - at a meeting in New York with Protein Sciences Corporation - they were informed that Protein Sciences will not be able to meet Diamyd Medical’s manufacturing needs for rhGAD65 as per a Purchase Agreement Order of August 8, 2017,  that was issued under the Development and Commercial Supply Agreement of July 12, 2008. Protein Sciences has offered to

Huatai Financial deploys Itiviti’s connectivity solution to trade via Shanghai-London Stock Connect

Hong Kong, October 17, 2019 – Itiviti, a leading technology and service provider to financial institutions worldwide, today announced that Huatai Financial Holdings (Hong Kong) Limited (Huatai Financial), a wholly-owned subsidiary of Huatai Securities, one of China’s largest brokerages, has successfully deployed Itiviti’s connectivity solution to expand its overseas footprint and provide new financing and investment services to its global clients.Itiviti’s connectivity solution, which includes UL Bridge, a renowned multi-protocol and low-latency connectivity platform as well as a powerful

Interim report January-September 2019

Quarter 3, 2019  · Incoming orders amounted to SEK 964.6m (817.9), which currency adjusted is an increase of 10.0 percent compared with the same period last year. · Net sales amounted to SEK 1,088.6m (835.2), which currency adjusted is an increase of 22.4 percent compared with the same period last year. · Operating profit amounted to SEK 77.9m (53.5)*, giving an operating margin of 7.2 percent (6.4)*. · Net profit amounted to SEK 52.8m (33.1)*. · Earnings per share amounted to SEK 1.50 kr (0.94).* January – September, 2019 · Incoming orders amounted to SEK 3,027.7m (

Sedana Medical’s nomination committee appointed

Sedana Medical AB (publ) today publish that in accordance with the resolution of the Annual General Meeting on May 28, 2019, the Chairman of the Board has contacted the company’s three largest shareholders or group of shareholders in terms of votes to form a Nomination Committee. These shareholders have been invited to appoint one representative each who, together with the Chairman of the Board, will comprise the Nomination Committee.Sedana Medical's Nomination Committee for the 2020 Annual General Meeting consists of: ·  Thomas Eklund, Chairman of the Board ·  Karl Tobieson,

Outokumpu – Publishing of the third-quarter 2019 results

Press releaseOctober 17, 2019 at 9.00 am EESTOutokumpu – Publishing of the third-quarter 2019 results Outokumpu will publish the third-quarter 2019 results on Thursday October 31, 2019 at approximately 9.00 am EET. A conference call for investors and analysts will be held on Thursday October 31, 2019 at 3.00 pm EET (8.00 am US EST, 1.00 pm UK, 2.00 pm CET). The results call will be hosted by Outokumpu’s CEO Roeland Baan and CFO Pia Aaltonen-Forsell. To participate in the conference call, please dial in 5−10 minutes before the beginning of the event: Finland: +358 9 424 50 806

Nordic Paper celebrating Paper Bag Day

October 18 is Paper Bag Day. A day initiated by the industry organization CEPI, which consists of Europe's leading kraft paper producers and paper bag producers. The focus is to create awareness around this environmentally superior bag.To mark the day and strike an extra punch for the natural alternative, several companies in Värmland - Nordic Paper, Coop Värmland, Norbag and Marvaco – has collaborated and created a ”Värmland bag” – from forest to table. Nordic Paper produces paper in Bäckhammar which is converted into a bag at Norbag in Töcksfors - where they are also printed with molds

Elisa’s Interim Report Q3 2019

ELISA CORPORATION INTERIM REPORT RELEASE 17 OCTOBER 2019 AT 8:30 AMThird quarter 2019 financial highlights · Revenue increased by EUR 11m to EUR 465m, mainly due to the Polystar acquisition and growth in mobile services. · Mobile service revenue increased by 2.3 per cent to EUR 208m. Competition has remained intense. · EBITDA, including the IFRS 16 change, grew by EUR 10m to EUR 179m. · EBIT, including the IFRS 16 change, increased by EUR 3m to EUR 113m. · Comparable cash flow grew by EUR 13m to EUR 98m mainly due to higher EBITDA and change in net working capital. ·

There are no items matching the current filter
There are no more items matching the current filter
Back to top